Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Consensus document on controversial issues in the treatment of complicated skin and skin-structure infections.

Pan A, Cauda R, Concia E, Esposito S, Sganga G, Stefani S, Nicastri E, Lauria FN, Carosi G, Moroni M, Ippolito G; GISIG (Gruppo Italiano di Studio sulle Infezioni Gravi) Working Group on Complicated Skin and Skin-Structure Infections.

Int J Infect Dis. 2010 Oct;14 Suppl 4:S39-53. doi: 10.1016/j.ijid.2010.05.007. Epub 2010 Sep 20.

PMID:
20851013
[PubMed - indexed for MEDLINE]
Free Article
2.

Consensus document on controversial issues for the treatment of hospital-associated pneumonia.

Franzetti F, Antonelli M, Bassetti M, Blasi F, Langer M, Scaglione F, Nicastri E, Lauria FN, Carosi G, Moroni M, Ippolito G; GISIG (Gruppo Italiano di Studio sulle Infezioni Gravi) Working Group on Hospital-Associated Pneumonia.

Int J Infect Dis. 2010 Oct;14 Suppl 4:S55-65. doi: 10.1016/j.ijid.2010.05.008. Epub 2010 Sep 22.

PMID:
20863734
[PubMed - indexed for MEDLINE]
Free Article
3.

Consensus document on controversial issues in the diagnosis and treatment of bloodstream infections and endocarditis.

Boumis E, Gesu G, Menichetti F, Ranieri M, Rinaldi M, Suter F, Nicastri E, Lauria FN, Carosi G, Moroni M, Ippolito G; GISIG (Gruppo Italiano di Studio sulle Infezioni Gravi) Working Group on Bloodstream Infections and Endocarditis.

Int J Infect Dis. 2010 Oct;14 Suppl 4:S23-38. doi: 10.1016/j.ijid.2010.05.006. Epub 2010 Sep 16.

PMID:
20843723
[PubMed - indexed for MEDLINE]
Free Article
4.

Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections.

Leone S, Borrè S, Monforte Ad, Mordente G, Petrosillo N, Signore A, Venditti M, Viale P, Nicastri E, Lauria FN, Carosi G, Moroni M, Ippolito G; GISIG (Gruppo Italiano di Studio sulle Infezioni Gravi) Working Group on Prosthetic Joint Infections.

Int J Infect Dis. 2010 Oct;14 Suppl 4:S67-77. doi: 10.1016/j.ijid.2010.05.005. Epub 2010 Sep 16.

PMID:
20843721
[PubMed - indexed for MEDLINE]
Free Article
5.

Consensus document on controversial issues for the treatment of infections of the central nervous system: bacterial brain abscesses.

Arlotti M, Grossi P, Pea F, Tomei G, Vullo V, De Rosa FG, Di Perri G, Nicastri E, Lauria FN, Carosi G, Moroni M, Ippolito G; GISIG (Gruppo Italiano di Studio sulle Infezioni Gravi) Working Group on Brain Abscesses.

Int J Infect Dis. 2010 Oct;14 Suppl 4:S79-92. doi: 10.1016/j.ijid.2010.05.010. Epub 2010 Sep 16.

PMID:
20846891
[PubMed - indexed for MEDLINE]
Free Article
6.

Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.

Prokocimer P, Bien P, Surber J, Mehra P, DeAnda C, Bulitta JB, Corey GR.

Antimicrob Agents Chemother. 2011 Feb;55(2):583-92. doi: 10.1128/AAC.00076-10. Epub 2010 Nov 29.

PMID:
21115795
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studies.

Krause KM, Barriere SL, Kitt MM, Benton BM.

Diagn Microbiol Infect Dis. 2010 Oct;68(2):181-5. doi: 10.1016/j.diagmicrobio.2010.05.008.

PMID:
20846593
[PubMed - indexed for MEDLINE]
8.

Clinical profile of ceftobiprole, a novel beta-lactam antibiotic.

Noel GJ.

Clin Microbiol Infect. 2007 Jun;13 Suppl 2:25-9. Review.

PMID:
17488373
[PubMed - indexed for MEDLINE]
9.

[Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms].

Martínez-Gómez Dde A, Ramírez-Almagro C, Campillo-Soto A, Morales-Cuenca G, Pagán-Ortiz J, Aguayo-Albasini JL.

Enferm Infecc Microbiol Clin. 2009 Jun;27(6):317-21. doi: 10.1016/j.eimc.2008.07.004. Epub 2009 Feb 23. Spanish.

PMID:
19237227
[PubMed - indexed for MEDLINE]
10.

Prospective, non-comparative study of daptomycin for the treatment of superficial and deep incisional surgical site infections.

Knapp AG, Kamepalli RK, Martone WJ, Yankelev S.

Surg Infect (Larchmt). 2011 Apr;12(2):113-8. doi: 10.1089/sur.2008.106. Epub 2011 Feb 24.

PMID:
21348765
[PubMed - indexed for MEDLINE]
11.

Gruppo Italiano di Studio sulle Infezioni Gravi - GISIG 3: controversial issues of severe bacterial infections due to multidrug-resistant Gram-positive bacteria: introduction by the National Coordinators.

Ippolito G, Moroni M, Carosi G.

Int J Infect Dis. 2010 Oct;14 Suppl 4:S1. doi: 10.1016/j.ijid.2010.05.001. Epub 2010 Sep 20. No abstract available.

PMID:
20851012
[PubMed - indexed for MEDLINE]
Free Article
12.

Telavancin Activity against gram-positive bacteria isolated from patients with skin and skin-structure infections.

Pfaller MA, Rhomberg PR, Sader HS, Mendes RE, Jones RN.

J Chemother. 2010 Oct;22(5):304-11.

PMID:
21123152
[PubMed - indexed for MEDLINE]
13.

Resistant and multi-resistant Gram-positive severe infections: the GISIG working methodology.

Lauria FN, De Carli G, Nicastri E.

Int J Infect Dis. 2010 Oct;14 Suppl 4:S13-7. doi: 10.1016/j.ijid.2010.05.004. Epub 2010 Sep 16.

PMID:
20843720
[PubMed - indexed for MEDLINE]
Free Article
14.

Antibiotic prophylaxis for the prevention of methicillin-resistant Staphylococcus aureus (MRSA) related complications in surgical patients.

Gurusamy KS, Koti R, Wilson P, Davidson BR.

Cochrane Database Syst Rev. 2013 Aug 19;8:CD010268. doi: 10.1002/14651858.CD010268.pub2. Review.

PMID:
23959704
[PubMed - indexed for MEDLINE]
15.

Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam.

Teppler H, McCarroll K, Gesser RM, Woods GL.

Surg Infect (Larchmt). 2002 Winter;3(4):337-49.

PMID:
12697080
[PubMed - indexed for MEDLINE]
16.

Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Group.

Nichols RL, Graham DR, Barriere SL, Rodgers A, Wilson SE, Zervos M, Dunn DL, Kreter B.

J Antimicrob Chemother. 1999 Aug;44(2):263-73. Erratum in: J Antimicrob Chemother 1999 Oct;44(4):585.

PMID:
10473234
[PubMed - indexed for MEDLINE]
Free Article
17.

The problem of complicated skin and skin structure infections: the need for new agents.

Moellering RC Jr.

J Antimicrob Chemother. 2010 Nov;65 Suppl 4:iv3-8. doi: 10.1093/jac/dkq250.

PMID:
21115452
[PubMed - indexed for MEDLINE]
Free Article
18.

A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria.

Katz DE, Lindfield KC, Steenbergen JN, Benziger DP, Blackerby KJ, Knapp AG, Martone WJ.

Int J Clin Pract. 2008 Sep;62(9):1455-64. doi: 10.1111/j.1742-1241.2008.01854.x. Epub 2008 Jul 25.

PMID:
18662172
[PubMed - indexed for MEDLINE]
19.

Efficacy of telavancin in patients with specific types of complicated skin and skin structure infections.

Stryjewski ME, Barriere SL, O'Riordan W, Dunbar LM, Hopkins A, Genter FC, Corey GR.

J Antimicrob Chemother. 2012 Jun;67(6):1496-502. doi: 10.1093/jac/dks081. Epub 2012 Mar 13.

PMID:
22416054
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk